Application no. and date | 13730352.5 (espacenet) (Federated) (European Patent Register), 20130510 | Patent/reg. no. and date | DK/EP 2846770, 20180613 | Publication date | 20150318 | Priority no. and date | IT MI20120814, 20120511 | EP pub. no. and date |
EP 2846770 20150318 | Effective date | | Applicant/owner | Dolcetta, Diego, Contra' Motton San Lorenzo 11
36100 Vicenza, IT | Applicant ref. no. | V1808-059-DK | Inventor | CASSANO, Tommaso, Via Padova 65
I-00161 Roma, IT, GIOVAGNOLI, Stefano, Via Mario Angeloni 49
I-06124 Perugia, IT, MAGINI, Alessandro, Via dell'Asilo 15
I-06122 Perugia, IT, EMILIANI, Carla, Strada Monte Bagnolo-Val Biancara 12A/1
I-06070 Cenerente (Perugia), IT | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/436 (2006.01) , A61K 9/08 (2006.01) , A61P 25/28 (2006.01) | Title | INTRATEKAL ADMINISTRATION AF MTOR-INHIBITORER TIL BEHANDLING AF NEURODEGENRATIVE, NEUROINFLAMMATORISKE OG NEUROONKOLOGISKE SYGDOMME | Int. application no. | IB2013053792 | Int. publication no. | WO2013168131 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|